Patent intelligence · US
US 11987821
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
Patent details — US 11987821
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 21, 2024
- Expiration
- May 16, 2044
- Applicant
- Entrada Therapeutics, Inc.
- Claims
- 18
- CPC classes
- A61K, A61K35/12, A61K38/45, A61K47/60
Quick answer
US 11987821 (Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy) is held by Entrada Therapeutics, Inc.. Status: granted. Granted May 21, 2024. Expires May 16, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Entrada Therapeutics, Inc.
- Grant date
- Expiration
- Claims
- 18
- CPC classes
- A61K, A61K35/12, A61K38/45, A61K47/60, A61K47/645
More from Entrada Therapeutics, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 11225506
Cell penetrating peptides and methods of making and using thereof
granted -
US 11168310
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
granted -
US 10815276
Cell penetrating peptides and methods of making and using thereof
granted -
US 10626147
Cell penetrating peptides and methods of making and using thereof
granted
Frequently asked questions
What is US patent 11987821?
US 11987821 (Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy) is held by Entrada Therapeutics, Inc.. Status: granted. Granted May 21, 2024. Expires May 16, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11987821?
Entrada Therapeutics, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 5 pharmaceutical patents for this assignee.
When does US 11987821 expire?
Our index shows an expiration date of May 16, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.